Back to Search

Phase I Study Evaluating Combination Therapy With the Receptor Tyrosine Kinase Inhibitor PLX3397 and Sirolimus in Patients With Unresectable Sarcoma and Phase II Study in Malignant Peripheral Nerve Sheath Tumors

  • Protocol Number: 201601048
  • Principal Investigator: Van Tine, Brian
  • Cancer Types: Sarcoma

For more information on this trial, contact us here:


Brief Summary

Protocol Interventions